AI uncovers potential cancer drivers hidden in ‘junk’ regions of DNA

FHS
July 3, 2024
3:28 am

Using artificial intelligence, Garvan Institute researchers have found potential cancer drivers hidden in so-called ‘junk’ regions of DNA, opening up possibilities for a new approach to diagnosis and treatment.

Cybin to Participate at the Pathways to Access Summit and the Interdisciplinary Conference on Psychedelic Research 2024 | Psychedelic Invest

TORONTO, May 29, 2024–(BUSINESS WIRE)–Cybin Inc. (NYSE American:CYBN) (Cboe CA:CYBN) (“Cybin” or the “Company“), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new

May 29, 2024

Editas trades part of Vertex CRISPR therapy licencing rights deal for $57m – Pharmaceutical Technology

CRISPR/Cas9 is a gene-editing technology that allows scientists to precisely cut and modify DNA in living organisms. Credit: Prostock-studio via Shutterstock. Amidst the long-running Cas9

October 6, 2024

Ipsen outlines $461m for ex-US rights to Day One’s glioma therapy

Day One’s Ojemda received accelerated approval from the US FDA to treat low-grade glioma in paediatric patients aged six months and older. Image Credit: Lightspring

July 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.